Publications by authors named "Ho Lim"

Claim this Profile
O
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.
Jung Sun Kim, Jeffrey Wong, San-Chi Chen, David Tai, Hannah Yang, Ho Yeong Lim

Liver Int· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study.
Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Jay J Shen, Minsuk Kwon, Ho Yeong Lim

Am J Prev Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study.
Hyun-Jin Kim, Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Jay J Shen, Ho Yeong Lim

Eur J Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study.
Pasquale Lombardi, Jung Sun Kim, Giulia F Manfredi, Ciro Celsa, Claudia A M Fulgenzi, Ho Yeong Lim

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential implications of tumor endothelial cell and lymphocyte densities in advanced hepatocellular carcinoma patients treated with immunotherapy.
Gwangil Kim, Beodeul Kang, Jung Yong Hong, Haeyoun Kang, Jung Sun Kim, Yoojoo Lim, Ho Yeong Lim

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of IMC-002, a Next-Generation Anti-CD47 Antibody, in Advanced Solid Tumors.
Jin Seok Ahn, Jung Yong Hong, Joon Oh Park, Sung Young Lee, SuYeon Kim, Ho Yeong Lim

Cancer Res Treat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Multi-Omics Profiling Identifies Infiltrative HCC as an Immunotherapy-Resistant Subtype with Distinct Molecular Features.
Won Suk Lee, Seonjeong Woo, Sung Hwan Lee, Gae Hoon Jo, Ilhwan Kim, Ho Yeong Lim

Clin Mol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of aberrations in pan-cancer, with a focus on prognostic and therapeutic implications.
Jaeyun Jung, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Sung Hee Lim

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery or chemotherapy first? Unveiling the best approach for colorectal cancer with resectable liver metastasis.
Seijong Kim, Jung Kyong Shin, Yoonah Park, Gyu-Seong Choi, Jung Wook Huh, Ho Yeong Lim

Surgery· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population.
Francesco Vitiello, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Ho Yeong Lim

Semin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study.
Yoon Jun Kim, Philippe Merle, Richard S Finn, Masatoshi Kudo, Heinz-Josef Klümpen, Ho Yeong Lim

Liver Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study.
Mara Persano, Andrea Casadei-Gardini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Ho Yeong Lim

Oncology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies.
Richard S Finn, Kangsheng Gu, Xi Chen, Philippe Merle, Kyung-Hun Lee, Ho Yeong Lim

JHEP Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study.
Jung Sun Kim, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Ho Yeong Lim

Cancer Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial.
George Lau, Bruno Sangro, Ann-Lii Cheng, Masatoshi Kudo, Robin Kate Kelley, Ho Yeong Lim

Hepatology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population.
Ho Yeon Lim, Hyun Sub Cheong, Seok Namgoong, Jong Hee Chang, Lyoung Hyo Kim

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrafast PCR assay for identification of three king crabs- and .
Ho Soo Lim, Eun Ji Park, Ja Hyun Lee, Hyung Soo Kim, Jae Eun Mun

Food Sci Biotechnol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scale to predict risk for refractory septic shock based on a hybrid approach using machine learning and regression modeling.
Sejin Heo, Daun Jeong, Minyoung Choi, Inkyu Kim, Minha Kim, Tae Ho Lim

Emergencias· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC.
Ho Yeong Lim, Jeong Heo, Julio A Peguero, Baek-Yeol Ryoo, Thomas Decaens

Hepatology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediabetes persistence or remission and subsequent risk of gallbladder cancer: A nationwide cohort study.
Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Young Suk Park, Joon Oh Park, Ho Yeong Lim

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Ho Yeong Lim

Liver Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice.
Ji Eun Shin, Sung Hee Lim, Jeeyun Lee, Ho Yeong Lim, Young Suk Park

Front Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394.
Shukui Qin, Weijia Fang, Zhenggang Ren, Shuangyan Ou, Ho Yeong Lim

Liver Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1.
Shin Woo Kang, Sung Hee Lim, Min-Ji Kim, Jeeyun Lee, Young Suk Park, Ho Yeong Lim

World J Gastrointest Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer.
Sung Hee Lim, Min Jung Kim, Jeeyun Lee, Ho Yeong Lim, Won Ki Kang

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis